HOTTIP and hepatocellular carcinoma: However, HOTTIP and HOXA13 have been associated with disease progression and worse outcome in hepatocellular carcinoma [22], with progression and gemcitabine resistance in pancreatic cancer [42], and with tumorogenesis and metastasis in esophageal squamous carcinoma [43] and gastric cancer [44].